Sign Up to like & get
recommendations!
0
Published in 2021 at "PharmacoEconomics"
DOI: 10.1007/s40273-021-01079-6
Abstract: The pipeline for new treatments for Alzheimer’s disease (AD) in the USA contains over 100 different agents, 80% of which can be categorized as disease-modifying therapies. The regulatory approval of the disease-modifying agent aducanumab has…
read more here.
Keywords:
alzheimer disease;
contextual considerations;
recommendations estimating;
value ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Current Opinion in Cardiology"
DOI: 10.1097/hco.0000000000000561
Abstract: PURPOSE OF REVIEW To address common concerns regarding sodium-glucose cotransporter 2 (SGLT2) inhibitor use for patients with type 2 diabetes mellitus (T2DM) in cardiovascular practice. RECENT FINDINGS SGLT2 inhibitors provide glycemic control and improve cardiovascular…
read more here.
Keywords:
sglt2 inhibitors;
sglt2;
practical considerations;
glycemic control ... See more keywords